OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Future of immune checkpoint inhibitors: focus on tumor immune microenvironment
Yunlong Jia, Lihua Liu, Baoen Shan
Annals of Translational Medicine (2020) Vol. 8, Iss. 17, pp. 1095-1095
Open Access | Times Cited: 34
Yunlong Jia, Lihua Liu, Baoen Shan
Annals of Translational Medicine (2020) Vol. 8, Iss. 17, pp. 1095-1095
Open Access | Times Cited: 34
Showing 26-50 of 34 citing articles:
Integrative bioinformatics and experimental analysis revealed down-regulated CDC42EP3 as a novel prognostic target for ovarian cancer and its roles in immune infiltration
Yuanliang Yan, Qiuju Liang, Zhijie Xu, et al.
PeerJ (2021) Vol. 9, pp. e12171-e12171
Open Access | Times Cited: 9
Yuanliang Yan, Qiuju Liang, Zhijie Xu, et al.
PeerJ (2021) Vol. 9, pp. e12171-e12171
Open Access | Times Cited: 9
Abscopal Effect and Drug-Induced Xenogenization: A Strategic Alliance in Cancer Treatment?
Ornella Franzese, Francesco Torino, Elisa Giannetti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10672-10672
Open Access | Times Cited: 9
Ornella Franzese, Francesco Torino, Elisa Giannetti, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10672-10672
Open Access | Times Cited: 9
Results from a Meta-analysis of Combination of PD-1/PD-L1 and CTLA-4 Inhibitors in Malignant Cancer Patients: Does PD-L1 Matter?
Yuqian Feng, Huimin Jin, Kaibo Guo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 8
Yuqian Feng, Huimin Jin, Kaibo Guo, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 8
Aberrant Expression of ADARB1 Facilitates Temozolomide Chemoresistance and Immune Infiltration in Glioblastoma
Can Lu, Xi Chen, Yuanliang Yan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Can Lu, Xi Chen, Yuanliang Yan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6
Identification and validation of an immune-related gene prognostic signature for clear cell renal carcinoma
Shan Hua, Zhiwen Xie, Yongqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Shan Hua, Zhiwen Xie, Yongqing Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Resistance to Immunotherapy: Mechanisms and Means for Overcoming
Mohamad A. Salkeni, John Y. Shin, James L. Gulley
Advances in experimental medicine and biology (2021), pp. 45-80
Closed Access | Times Cited: 6
Mohamad A. Salkeni, John Y. Shin, James L. Gulley
Advances in experimental medicine and biology (2021), pp. 45-80
Closed Access | Times Cited: 6
Persistent immune response: Twice tumor exfoliation induced by sialic acid–modified vincristine sulfate liposomes
Xinyang Yan, Xin Gao, Xiaoya Li, et al.
International Journal of Pharmaceutics (2022) Vol. 631, pp. 122467-122467
Closed Access | Times Cited: 4
Xinyang Yan, Xin Gao, Xiaoya Li, et al.
International Journal of Pharmaceutics (2022) Vol. 631, pp. 122467-122467
Closed Access | Times Cited: 4
PD-1 blockage combined with vaccine therapy can facilitate immune infiltration in tumor microenvironment of Lynch syndrome colon cancer
Kai Ye, Wenjin Zhong, Pengcheng Wang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Kai Ye, Wenjin Zhong, Pengcheng Wang, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Infection-related Hospitalizations During Immune Checkpoint Inhibitor Treatment Without Immunosuppressants
Ye Sul Jeung, June Young Chun, Beom K. Choi, et al.
Journal of Immunotherapy (2024) Vol. 47, Iss. 4, pp. 139-147
Closed Access
Ye Sul Jeung, June Young Chun, Beom K. Choi, et al.
Journal of Immunotherapy (2024) Vol. 47, Iss. 4, pp. 139-147
Closed Access
Immuno-PET Molecular Imaging of RANKL in Cancer
Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2166-2166
Open Access | Times Cited: 3
Jonatan Dewulf, Christel Vangestel, Yannick Verhoeven, et al.
Cancers (2021) Vol. 13, Iss. 9, pp. 2166-2166
Open Access | Times Cited: 3
